CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Canadian Journal of Health Technologies

Menu
Begin main content
Home Reports Bisphosphonate Use in Patients with Osteopenia and Low Risk of Fractures: Clinical Effectiveness and Guidelines
Back to Reports

Bisphosphonate Use in Patients with Osteopenia and Low Risk of Fractures: Clinical Effectiveness and Guidelines

Last updated: April 17, 2015
Project Number: RB0842-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of bisphosphonates in patients with osteopenia at low risk of fracture?
  2. What are the evidence based guidelines associated with the use of bisphosphonates in patients with osteopenia at low risk of fracture?

Key Message

Seven systematic reviews and one evidence-based guideline were identified regarding the use of bisphosphonates in patients with osteopenia at low risk of fracture.

Files

Bisphosphonate Use in Patients with Osteopenia and Low Risk of Fractures: Clinical Effectiveness and Guidelines

Rapid Response

Summary of Abstracts

  • Published: April 17, 2015